Show simple item record

dc.identifier.urihttp://hdl.handle.net/11401/76499
dc.description.sponsorshipThis work is sponsored by the Stony Brook University Graduate School in compliance with the requirements for completion of degree.en_US
dc.formatMonograph
dc.format.mediumElectronic Resourceen_US
dc.language.isoen_US
dc.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dc.typeDissertation
dcterms.abstractSCCA1 is a member of the serine/cysteine protease inhibitor (serpin) family whose intracellular targets include lysosomal cathepsins L, S and K. Its expression correlates with resistance to cell death resulting from lysosomal membrane permeabilization and cathepsin release in response to radiation and chemotherapy. Elevated SCCA1 expression has been reported in a wide array of cancers including squamous cell carcinomas of the lung, head and neck, skin, cervix, as well as hepatocellular carcinoma. Our laboratory recently found that increased expression of SCCA1 also correlates with high-grade, poorly differentiated breast carcinoma and poor prognosis. However, despite SCCA1's clear relevance in human cancer, its molecular and biological function remain largely unclear. In my dissertation research, I find that ectopic expression of SCCA1 in the non-tumorigenic mammary epithelial cell line MCF10A leads to epithelial-mesenchymal transition (EMT), a key molecular program that is co-opted by invasive and metastatic cancer cells. Correlatively, SCCA1 leads to oncogenic transformation in cultured cells as well in tumor xenografts. Silencing of endogenous SCCA1 in multiple breast cancer cell lines led to attenuation of cell growth. Mechanistically, SCCA1 interferes with cellular protein homeostasis resulting in a persistent yet sub-lethal level of endoplasmic reticulum stress leading to the activation of the unfolded protein response (UPR). This chronic stress results in NF-κ B activation and induces the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) that drives EMT and oncogenic transformation. In the MMTV-Neu mouse mammary tumor model, expression of SCCA1 leads to an invasive phenotype with an exaggerated stress response and immune cell infiltration. These findings uncover a previously unknown role for SCCA1 in promoting tumorigenesis by inducing UPR, NF-κ B activation, and pro-tumorigenic cytokine production.
dcterms.available2017-09-20T16:50:26Z
dcterms.contributorBrown, Deborahen_US
dcterms.contributorZong, Wei-Xingen_US
dcterms.contributorChen, Emilyen_US
dcterms.contributorHayman, Michael Jen_US
dcterms.contributorCrawford, Howard.en_US
dcterms.creatorSheshadri, Namratha
dcterms.dateAccepted2017-09-20T16:50:26Z
dcterms.dateSubmitted2017-09-20T16:50:26Z
dcterms.descriptionDepartment of Molecular and Cellular Biology.en_US
dcterms.extent106 pg.en_US
dcterms.formatApplication/PDFen_US
dcterms.formatMonograph
dcterms.identifierhttp://hdl.handle.net/11401/76499
dcterms.issued2014-12-01
dcterms.languageen_US
dcterms.provenanceMade available in DSpace on 2017-09-20T16:50:26Z (GMT). No. of bitstreams: 1 Sheshadri_grad.sunysb_0771E_12027.pdf: 1954825 bytes, checksum: 46ce4f77fe9a8f96fdfd231a3a6fa007 (MD5) Previous issue date: 1en
dcterms.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dcterms.subjectMolecular biology
dcterms.subjectBreast, cancer, EMT, IL-6, SCCA, UPR
dcterms.titleSquamous Cell Carcinoma Antigen 1 (SCCA1) promotes mammary tumorigenesis by inducing the Unfolded Protein Response (UPR) and IL-6 signaling
dcterms.typeDissertation


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record